Ronald Plasterk

Company: CureVac

Job title: Senior Vice President Science and Innovation

Seminars:

Examining Second Generation Cancer Vaccines 12:00 pm

Understanding how the bulk of neoantigens within the exome are SNPs, mostly resulting in single amino acid changes, necessitating the selection of neoantigens predicted to be immunogenic Evaluating how current technology allows fast Whole Genome Sequencing, deep long-read sequencing of intact complete mRNAs, and the bioinformatics capacity to handle this information Examining how using this…Read more

day: Conference Day One